Regulation of p16INK4a, senescence and oncogenesis;Régulation de p16INK4a, sénescence et oncogenèse

Medecine/Sciences

Volumn 22, Issue 10, 2006, Pages 865-871

  Chien, Wei Wen ^a   Ffrench, Martine ^b  

^a UNIVERSITÉ LYON 1   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DNA METHYLTRANSFERASE; HETERODIMER; HISTONE H3; HISTONE H4; LYSINE; PROTEIN P16INK4A; PROTEIN SWI; RNA HELICASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BMI 1; TRANSCRIPTION FCATOR E47; TRANSCRIPTION FCATOR ETS1; TRANSCRIPTION FCATOR ETS2; UNCLASSIFIED DRUG;

CARCINOGENESIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; COMPLEX FORMATION; CPG ISLAND; DEACETYLATION; DIMERIZATION; DNA METHYLATION; EPIGENETICS; EXON; GENE SILENCING; HUMAN; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN METHYLATION; REVIEW; SENESCENCE; TRANSCRIPTION REGULATION; AGING; ANIMAL; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; NEOPLASM; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

AGING; ANIMALS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENES, P16; HUMANS; NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 33750039375     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20062210865     Document Type: Review

References (49)

1. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD/CDK4. Nature 1993; 366: 704-7.
2. Wolff B, Naumann M. INK4 cell cycle inhibitors direct transcriptional inactivation of NF-kappaB. Oncogene 1999; 18: 2663-6.
3. Haas K, Staller P, Geisen C, et al. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc. Oncogene 1997; 10: 179-92.
4. Serizawa H. Cyclin-dependent kinase inhibitor p16INK4A inhibits phosphorylation of RNA polymerase II by general transcription factor TFIIH. J Biol Chem 1998; 273: 5427-30.
5. Nobori T, Miura K, Wu DJ, et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753-6.
6. Merlo A, Herman JG, Mao L, et al. 5′pG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995; 1: 686-92
7. Sandig V, Brand K, Herwig S, et al. Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat Med 1997; 3: 313-9.
8. Kim M, Katayose X, Rojanala L, et al. Induction of apoptosis in p16INK4A mutant cell lines by adenovirus-mediated overexpression of p16INK4A protein. Cell Death Differ 2000; 7: 706-11.
9. Ausserlechner MJ, Obexer P, Geley S, et al. G1 arrest by p16INK4A uncouples growth from cell cycle progression in leukemia cells with deregulated cyclin E and c-Myc expression. Leukemia 2005; 19: 1051-7.
10. Sharpless NE, DePinho RA. The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev 1999; 9: 22-30
11. CDKN2 expression and its implication for cell immortalization and senescence. Mol Cell Biol 1996; 16: 859-67
12. Li V, Nicolas MA, Shay JW, et al. Transcriptional repression of the D-type cyclin dependent kinase inhibitor p16 by retinoblastoma susceptibility gene product pRb. Cancer Res 1994; 54: 6078-82.
13. INK4a. Cell 1997; 88: 593-602.
14. Zhang V, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the pRb and p53 tumor suppression pathways. Cell 1998; 92: 725-34.
15. ink4a participates in a G1 arrest checkpoint in response to DNA damage. Mol Cell Biol 1998; 18: 378-87.
16. Krimpenfort P, Quon K.C, Mooi WJ, et al. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Mature 2001; 413: 83-6.
17. Serrano M, Lee H, Chin L, et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996; 85: 27-37.
18. Brookes S, Rowe J, Ruas M, et al. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J 2002; 21: 2936-45.
19. Drayton S, Rowe J, Jones R, et al. Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. Cancer Cell 2003; 4: 301-10
20. Gump J, Stokoe D, McCormick F. Phosphorylation of p16INK4A correlates with Cdk4 association. J Biol Chem 2003; 278: 6619-22.
21. Mekki Y, Catallo R, Bertrand Y, et al. Enhanced expression of p16ink4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Leukemia 1999; 13: 181-9.
22. Zhu J, Woods D, McMahon M, et al. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev 1998; 12: 2997-3007.
23. INK4a expression during cellular senescence. Nature 2001; 409: 1067-70.
24. INK4a-pRb pathway by promoting nuclear export of E2F4/5. J Cell Biol 2003; 162: 173-83.
25. Pagliuca A, Gallo P, De Luca P, et al. Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth. Cancer Res 2000; 60: 1376-82
26. INK4a expression by Id1 and E47 proteins in human diploid fibroblast. J Biol Chem 2004; 279: 31524-32.
27. Hansson A, Manetopoulos C, Jönsson JI, et al. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pT genes. Biochem Biophys Res Commun 2003; 312: 1073-81.
28. Hara E, Yamaguchi T, Nojima H, et al. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem 1994; 269: 2139-45.
29. Alani RM, Young AZ, Shifflett CB. Id1 regulation of cellular senescence through transcriptional repression of p16/INK4a. Proc Natl Acad Sci USA 2001; 98: 7812-6.
30. Nickoloff BJ, Chaturvedi V, Bacon P, et al. Id-1 delays senescence but does not immortalize keratinocytes. J Biol Chem 2000; 275: 27501-4.
31. Tang J, Gordon GM, Nickoloff BJ, et al. The helix-loop-helix protein Id-1 delays onset of replicative senescence in human endothelial cells. Lab Invest 2002; 82: 1073-9.
32. INK4a, Id1, is up-regulated in early melanomas. Cancer Res 2001; 61: 6008-11.
33. Pesce S, Benezra R. The loop region of the helix-loop-helix protein Id1 is critical for its dominant negative activity. Mol Cell Biol 1993; 13: 7874-80.
34. Jacobs JJL, Kieboom K, Marino S, et al. The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the INK4a locus. Nature 1999; 397: 164-8.
35. Itahana K, Zou Y, Itahana Y, et al. Control of the replicative life span of human fibroblasts by p16 and polycomb protein Bmi-1. Mol Cell Biol 2003; 23: 389-401.
36. Dellino GI, Schwartz YB, Farkas G, et al. Polycomb silencing blocks transcription initiation. Mol Cell 2004; 13: 887-93.
37. Costello JF, Berger MS, Huang HS, et al. Silencing of p16/CDKN2 expression in humain gliomas by methylation and chromatin condensation. Cancer Res 1996; 56: 2405-10.
38. WAF/Cip1 by distinct mechanisms. J Biol Chem 1999; 274: 24250-6.
39. Robert MF, Morin S, Beaulieu N, et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 2003; 33: 61-5.
40. Bachman KE, Park BH, Rhee I, et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer cell 2003; 3: 89-95.
41. Magdinier F, Wolffe AP. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc Natl Head Sci USA 2001; 98: 4990-5
42. INK4a and hMLH1 genes. Mol Cell Biol 2005; 25: 4388-96.
43. Ng HH, Zhang V, Hendrich B, et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet 1999; 23: 58-61.
44. INK4a promoter. J Biol Chem 2001; 276: 1634-42.
45. INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells. J Biol Cnem 2004; 279: 3807-16.
46. Cao R, Wang L, Wang H, et al. Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science 2002; 298: 1039-43.
47. Passegue E, Magner EF. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J 2000; 19: 2969-79.
48. INK4a that contribute to overexpression of p16 in senescent fibroblasts. J Biol Cnem 2001; 276: 48655-61.
49. Jacobs JJ, Scheijen B, Voncken JN, et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 1999; 13: 2678-90.